PMA supplement
P140018 S026: Venaseal Closure System
FDA PMA supplement · 135 Review Track For 30-Day Notice · Medtronic Vascular, Inc.
Key facts
| Original PMA | P140018 |
|---|---|
| Supplement number | S026 |
| Supplement type | 135 Review Track For 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | Venaseal Closure System |
| Generic name | Agent, occluding, vascular, permanent |
| Applicant | Medtronic Vascular, Inc. |
| Product code | PJQ |
| Received date | May 17, 2021 |
| Decision date | Jan 27, 2022 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: